Clinical trial
A Randomised, Cross-over, Open-label, Multi-centre Trial Comparing the Effect of Insulin Degludec and Insulin Glargine 100U/mL, With or Without OADs in Subjects With Type 2 Diabetes Using Flash Glucose Monitoring
NCT03687827 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Cross-over, Open-label, Multi-centre Trial Comparing the Effect of Insulin Degludec and Insulin Glargine 100U/mL, With or Without OADs in Subjects With Type 2 Diabetes Using Flash Glucose Monitoring
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 2, 2018
- Completion date
- December 27, 2019
- Enrollment
- 498 (actual)
- Sites
- 67
Conditions
As the registry lists them; a condition with its own page is linked.